Malignant Liver Neoplasm — Trials

Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,120 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 906
Recruiting: 530
Ph III recruiting: 46
Growth YoY: +4.5%
Industry share: 21%
Top sponsor: Sun Yat-sen University
Termination share: 32.5%
Trials / 1,000 deaths: 30.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (459)

clinicaltrialsPublishedShowing 101–136 of 136 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05072041	Safety and Efficacy of Degradable Microsphere in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma	recruiting	N/A	150	Next Biomedical Co., Ltd.INDUSTRY	1	Nov 14, 2024	clinicaltrials
NCT05887661	Goal-directed LCVP Based on HP in Laparoscopic Hepatectomy	recruiting	N/A	100	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	1	Nov 12, 2024	clinicaltrials